2025-03-29 13:27:34
Latest Post
Cineline India Ltd monetizes Hotel Asset for INR 270 crores, becomes Net Debt-Free company
Emami Realty Limited appoints Ms. Ishani Ray as additional director
The Ramco Cements Ltd increases cement grinding capacity by 0.4 MTPA
Manappuram Finance Limited board approves fund raising program for FY 2025-26
Adani Renewable Energy Fifty Seven Ltd commissions incremental solar power project of 37.50 MW at Khavda
Stock Report
Rossari Biotech Ltd Q2FY23 consolidated net profit falls to Rs. 23.91 crores
Posted On : 2022-11-05 23:00:55( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 426.256 crores during the period ended September 30, 2022 as compared to Rs. 435.454 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 23.916 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 28.681 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 4.32 for the period ended September 30, 2022 as compared to Rs. 5.18 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 426.256 crs | ₹435.454 crs |  -2.11% |
| Net Profit | ₹23.916 crs | ₹28.681 crs | -16.61% |
| EPS | ₹4.32 | ₹5.18 | -16.60% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 426.256 crores during the period ended September 30, 2022 as compared to Rs.386.853 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.23.916 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.26.229 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.4.32 for the period ended September 30, 2022 as compared to Rs.4.74 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 426.256 crs | ₹386.853 crs |  10.19% |
| Net Profit | ₹23.916 crs | ₹26.229 crs | -8.82% |
| EPS | ₹4.32 | ₹4.74 | -8.86% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.861.710 crores during the 6 Months period ended September 30, 2022 as compared to Rs.620.295 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.52.597 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.50.751 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.9.49 for the 6 Months period ended September 30, 2022 as compared to Rs.9.23 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹861.710 crs | ₹620.295 crs | 38.92% |
| Net Profit | ₹52.597 crs | ₹50.751 crs | 3.64% |
| EPS | ₹9.49 | ₹9.23 | 2.82% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 888.15 as compared to the previous close of Rs. 898.65. The total number of shares traded during the day was 8448 in over 1412 trades.
The stock hit an intraday high of Rs. 908.70 and intraday low of 882.15. The net turnover during the day was Rs. 7567272.00.
